On 8:00 am EST, Monday November 23, 2009

Cord Blood America CEO Matthew Schissler Interviewed on Company's Progress

Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that an updated progress interview with CEO and co-founder Matthew Schissler is now available.

The entire interview is at: http://blip.tv/file/2875811 .

In the interview, Mr. Schissler updates progress at the Company's laboratory in Las Vegas, answers questions asked on the Company's "Facebook" fan page, and shows off the new facility for investors to view.

"My message is: 2010 will focus on top-line revenue growth including organic growth, acquisitions, and diversifying the revenue streams," Cord Blood America's CEO said.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at www.corcell.com. For investor information, visit http://www.cordblood-america.com.

ABOUT Nebulastocks.com http://www.nebulastocks.com/ http://nebulastocks.ning.com/

Nebulastocks is a leading stock website that provides FREE newsletters on stocks that are potential huge movers and also tracks micro cap stocks that could be undervalued by the market. Nebulastocks.com strives to provide an edge to Traders and Investors with its FREE newsletter service.

Nebulastocks.com is an independent electronic publication that provides information on selected publicly traded companies. Nebulastocks.com s not a registered investment advisor or broker-dealer. Nebulastocks.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise. in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

CONTACT: Nebulastocks.com WWW: http://www.nebulastocks.com/

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

In the interview, Mr. Schissler updates progress at the Company's laboratory in Las Vegas, answers questions asked on the Company's "Facebook" fan page, and shows off the new facility for investors to view.

"My message is: 2010 will focus on top-line revenue growth including organic growth, acquisitions, and diversifying the revenue streams," Cord Blood America's CEO said.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit http://www.cordblood-america.com.

    CONTACT:
    Paul Knopick
    E & E Communications
    949/707-5365
    pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.

http://www.cordblood-america.com

"Gross margins increased from 54.3 to 62.7 percent as we emphasized our higher margin cord blood storage business instead of our advertising division, which we are phasing out," said Mr. Schissler. "We expect an increase in this important trend in 2010." Cord Blood America also noted that expenses increased in the quarter, with construction of the Company's new laboratory in Las Vegas. A decrease in revenues is attributable to a de-emphasis on the advertising business coupled with difficult economic conditions. The decrease to $838,238 in the third quarter and $2.6 million for the first nine months of 2009 is compared to $927,359 and $3.3 million in the comparable periods in 2008.

"The year 2009 focused on cleaning up the balance sheet and our third quarter results continue to validate our progress. The year 2010 will be laser focused on leveraging opportunities with our new laboratory, with special emphasis on diversifying revenue streams. Organic growth in the core stem cell processing and storage business and accretive acquisitions will also be primary targets for increasing the top line in 2010," said Mr. Schissler.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com

Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/c/stock-pr

About CRWENews.com

CRWENews.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENews.com is a division of Crown Equity Holdings, Inc.

CRWENews.com is not a registered investment advisor or broker-dealer. CRWENews.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

We encourage investors to join and receive CRWENews.com FREE e-mail news and stock watch alerts at http://www.crwenewswire.com/c/stock-pr and view our full disclaimer.

Forward-Looking Statement: This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements and/or Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

CONTACT: Kenneth Bosket, Crown Equity Holdings, Inc. e-mail: ccollins@crownequityholdings.com Tel: +1 702 448 1543 Fax: +1 702 258 9007

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

"Gross margins increased from 54.3 to 62.7 percent as we emphasized our higher margin cord blood storage business instead of our advertising division, which we are phasing out," said Mr. Schissler. "We expect an increase in this important trend in 2010." Cord Blood America also noted that expenses increased in the quarter, with construction of the Company's new laboratory in Las Vegas. A decrease in revenues is attributable to a de-emphasis on the advertising business coupled with difficult economic conditions. The decrease to $838,238 in the third quarter and $2.6 million for the first nine months of 2009 is compared to $927,359 and $3.3 million in the comparable periods in 2008.

"The year 2009 focused on cleaning up the balance sheet and our third quarter results continue to validate our progress. The year 2010 will be laser focused on leveraging opportunities with our new laboratory, with special emphasis on diversifying revenue streams. Organic growth in the core stem cell processing and storage business and accretive acquisitions will also be primary targets for increasing the top line in 2010," said Mr. Schissler.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

    CONTACT:
    Paul Knopick
    E & E Communications
    949/707-5365
    pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.

http://www.cordblood-america.com